NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/25/2026
Back to search
Official data from USPTO
KYXINKO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
06/25/2026
Trademark type
Word
Nice classes
5
Filing date
11/06/2020
Registration date
09/20/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/20/2022
Last transaction
06/25/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
ES
Examiner
LOBO, DEBORAH E
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
LABORATORIOS FARMACEUTICOS ROVI, S.A.
Representatives
Andrew M. Smith Resonate IP, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productsantibioticsanalgesicsanesthetics for surgical and non-surgical useamino acids for medical useantisepticstranquilizerscollyriumsdigestives for pharmaceutical purposeslaxativesprescription synthetic narcotics; chemical products for medical usepharmaceuticals for treating schizophrenia; chemical pharmaceuticals preparations for the treatment of central nervous system diseases; medicines for the treatment of headache in the form of tonics; tranquillizers; soporifics; antipsychotics; medicated serums for the treatment of eczema; hormones; contraceptive preparations; vaccinessyringesvialscartridges or carpules and ampoules for medical purposesall sold pre-filled with pharmaceutical preparations in the nature of antipsychotics; implantable subcutaneous pharmaceutical delivery devices sold pre-filled with insulin; implantable drug delivery devices sold pre-filled with contraceptives; Pharmaceuticalsoncological preparations for the treatment of cancer; preparations for the treatment of diseases of the central nervous system; preparations for the treatment of schizophrenia; preparations for the treatment of hormonal disorders; preparations for the treatment of allergiesfor disorders of the skinthrombosiscoagulation diseasesinfectionsflupain and inflammation; tranquilizersprescription synthetic narcoticsantidepressantsanxiolytics; chemical pharmaceuticals for the treatment of diseases of the central nervous system; disposable syringes sold pre-filled with pharmaceutical preparations for treatment of central nervous system diseases
Publications
History of USPTO decisions and trademark events.
39 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/27/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/27/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/27/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/27/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/27/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/15/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/22/2022
FIMP
FINAL DISPOSITION PROCESSED
12/22/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/20/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/20/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/20/2022
GPNX
NOTIFICATION PROCESSED BY IB
07/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/05/2022
PUBO
PUBLISHED FOR OPPOSITION
07/05/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/15/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/15/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/15/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/30/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
05/30/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/30/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
05/30/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/30/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/25/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/20/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/20/2022
RFNT
REFUSAL PROCESSED BY IB
03/13/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/24/2022
RFRR
REFUSAL PROCESSED BY MPU
02/24/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/29/2022
CNRT
NON-FINAL ACTION WRITTEN
01/28/2022
DOCK
ASSIGNED TO EXAMINER
01/22/2022
MAFR
APPLICATION FILING RECEIPT MAILED
01/15/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/11/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
01/07/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/24/2020
Continuous trademark protection
Get notified about every new filing that threatens KYXINKO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.